2m 2m 2m 2m 2m 2m 2m
REVELATN BIO (REVB)
NASDAQ
$1.01-$0.05 (-4.34%)
Price as of Jun 03, 2026 7:35 PM EDT- $4.3MMarket Cap
- -90.19%1-Year Change
- BiotechnologyIndustry
REVELATN BIO (REVB)
$1.01-$0.05 (-4.34%)
REVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.06 | ||
Change | -$0.03 (-2.75%) | ||
Open | $1.08 | ||
High | $1.08 | ||
Low | $1.05 | ||
Previous Close | $1.09 | ||
Volume | 52,419 | ||
30-Day Average Volume | 59,749 | ||
1-Week Change | 0.00% | ||
1-Month Change | -5.36% | ||
1-Year Change | -90.19% | ||
3-Year Change | -99.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.9M | ||
Total Assets | $15.0M | ||
Market Cap | $4.3M | ||
Enterprise Value | -$9.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.0M | ||
Free Cash Flow | -$3.3M | ||
EBIT | -$3.0M | ||
EBITDA | -$3.0M | ||
Net Working Capital | $12.8M | ||
EPS | -$2.71 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 01/28/2026 | ||
Earnings & Revenue